Oscar López, MD, FAAN, University of Pittsburgh, Pittsburgh, PA, talks about the approval of aducanumab for treating patients with early-stage Alzheimer’s disease (AD) and discusses the potential of anti-amyloid drugs for treating early-stage AD. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.
